Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Apr 7;21(8):1479–1487. doi: 10.1016/j.bbmt.2015.04.004

Appendix 3.

Appendix 3

Appendix 3

Illustration of the independent associations between HCT-CI scores of 0, 1–2, and ≥3 and risks of NRM and overall mortality among recipients of allogeneic HCT, who were diagnosed with A) myeloid or B) lymphoid malignancies using Cox regression models.